Bassem Toeama

Bassem Toeama has a diverse work experience spanning over several years. Bassem is currently a member of the Executive Dashboard at Boardsi and a consultant for the World Health Organization. Prior to these roles, they founded and served as the CEO of MD Pharma Consulting Group and BeMe.ai. Bassem also worked as the LMCC and ECFMG Licensing Exams Program Director at Edge Plus Inc. Bassem Toeama has a strong educational background, having been a graduate researcher at the University of Toronto, Centre universitaire de santé McGill et IR-CUSM | McGill University Health Centre and RI-MUHC, and the University of Oxford. Bassem'searly professional experience includes working as a Hematology-Medical Oncology Specialist at Saad Specialist Hospital.

Bassem Toeama has an extensive education history. Bassem started their educational journey at Cairo University, where they obtained their Doctor of Medicine degree in Medicine from 1988 to 1996. Later, they pursued a Master of Science degree in Internal Medicine at Cairo University from 1998 to 2002.

To further enhance their expertise, Toeama joined the University of Oxford from 2008 to 2011, where they achieved a Master of Science degree in Experimental Therapeutics. Bassem then proceeded to McGill University from 2012 to 2014, where they obtained a Master of Science degree in Experimental Medicine.

Continuing their academic pursuits, Toeama enrolled at the University of Toronto from 2016 to 2020, where they earned a Doctor of Philosophy degree in Health Technology Assessment.

In addition to their formal degrees, Toeama has pursued additional certifications. However, information regarding the institutions from which these certifications were obtained, as well as the months and years of attainment, is not provided in the given information. The additional certifications include AMFR, CLBA, ECFMG, IELTS, and TOEFL.